Bardin Hill Management Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bardin Hill Management Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-170,108	Closed	-$36.9M	–	102
2021 Q1	$36.9M	Buy	+170,108	New	+$32M	6.84%	2

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Bardin Hill Management Partners's GWPH Position: Q2 2021 in Review

Bardin Hill Management Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 170,108 shares — an estimated $36.9M sold.

Bardin Hill Management Partners first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $36.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Bardin Hill Management Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Bardin Hill Management Partners sold 170,108 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $36.9M.
Bardin Hill Management Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Bardin Hill Management Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $36.9M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Bardin Hill Management Partners's 13F filing for Q2 2021, filed 16 Aug 2021.